- Exchange: Berlin
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Anacor Pharmaceuticals Inc
+ Add to Watchlist44A:GR
4.195 EUR 0.001 0.02%As of 02:05:12 ET on 05/24/2013.
Company Profile for Anacor Pharmaceuticals Inc (44A)
Anacor Pharmaceuticals Inc. is a biopharmaceutical company developing small-molecule therapeutics derived from our boron chemistry platform. The Company is focused on developing topical applications to treat fungal, bacterial and inflammatory diseases.
Contact Information
Anacor Pharmaceuticals Inc
1020 East Meadow Circle
Palo Alto, CA 94303-4230
United States
Key Executives for Anacor Pharmaceuticals Inc (44A)
| David P PerryPresident/CEO | Geoffrey M ParkerSenior VP/CFO |
| Kirk R MaplesSenior VP:Program Management | Jacob J PlattnerSenior VP:Research |
| Sanjay ChandaVP/Interim Head:Drug Dev | Lee T ZaneVP:Clinical Development |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Advertisements
Rate this Page